[25-NSE] scPharmaceuticals Inc. SEC Filing
scPharmaceuticals Inc. submitted a Form 25 notification indicating the company's class of securities will be removed from listing and/or registration on the Nasdaq Stock Market LLC. The form identifies Nasdaq as the exchange and cites the applicable withdrawal/delisting rule provisions. The filing indicates the Exchange and/or Issuer has followed the procedural rules governing a voluntary withdrawal under the Exchange Act.
scPharmaceuticals Inc. ha presentato una notifica Form 25 che indica che la classe di titoli della società verrà rimossa dall'elenco e/o dalla registrazione sul Nasdaq Stock Market LLC. Il modulo identifica Nasdaq come mercato di scambio e cita le disposizioni rilevanti delle norme per il ritiro/delisting. La compilazione indica che la Borsa e/o l’emittente ha seguito le regole procedurali che governano un ritiro volontario ai sensi del Securities Exchange Act.
scPharmaceuticals Inc. presentó una Notificación Form 25 indicando que la clase de valores de la empresa será retirada de la cotización y/o del registro en el Nasdaq Stock Market LLC. El formulario identifica a Nasdaq como la bolsa y cita las disposiciones aplicables de retiro/eliminación de listado. El informe indica que la Bolsa y/o el Emisor ha seguido las reglas procesales que rigen una retirada voluntaria conforme a la Exchange Act.
scPharmaceuticals Inc.는 회사의 증권 계열이 나스닥 주식시장 LLC에서 상장 및/또는 등록에서 제거될 것임을 알리는 Form 25 알림을 제출했습니다. 양식은 나스닥을 거래소로 식별하고 해당 인출/상장폐지 규정 조항을 인용합니다. 제출서는 거래소 및/또는 발행인이 Exchange Act에 따라 자발적 인출을 관리하는 절차 규칙을 따랐다고 명시합니다.
scPharmaceuticals Inc. a déposé une notification Form 25 indiquant que la catégorie de valeurs mobilières de la société sera retirée de la cotation et/ou de l'enregistrement sur le Nasdaq Stock Market LLC. Le formulaire identifie Nasdaq comme la bourse et cite les dispositions applicables des règles de retrait/désinscription. Le dépôt indique que la Bourse et/ou l'Émetteur a suivi les règles procédurales régissant un retrait volontaire en vertu de la Exchange Act.
scPharmaceuticals Inc. hat eine Form 25-Mitteilung eingereicht, die darauf hinweist, dass die Wertpapierklasse des Unternehmens aus dem Listing und/oder der Registrierung am Nasdaq Stock Market LLC entfernt wird. Das Formular identifiziert Nasdaq als Börse und verweist auf die einschlägigen Bestimmungen der Abzugs-/Delisting-Regeln. Die Einreichung gibt an, dass die Börse und/oder der Emittent die Verfahrensregeln befolgt hat, die eine freiwillige Entfernung gemäß dem Exchange Act regeln.
scPharmaceuticals Inc. قدمت إشعار Form 25 يشير إلى أن فئة الأوراق المالية للشركة ستُزال من القيد و/أو التسجيل في Nasdaq Stock Market LLC. يحدد النموذج Nasdaq كالبورصة ويرد أحكام إزالة/إسقاط الإدراج ذات الصلة. يشير الملف إلى أن البورصة و/أو المصدر قد اتبعا القواعد الإجرائية التي تحكم الانسحاب الاختياري بموجب قانون التبادل.
scPharmaceuticals Inc. 已提交一份Form 25通知，表明公司证券类别将从纳斯达克交易所有限责任公司的上市和/或注册中撤离。该表格将纳斯达克识别为交易所，并引用适用的撤回/摘牌规则条款。文件披露交易所和/或发行方已遵循管辖自愿撤回的程序规则，符合《交易法》。
- Procedural compliance indicated with applicable Exchange Act rule citations
- Notification filed formally via Form 25, initiating orderly removal process
- Delisting from Nasdaq which may reduce liquidity for the listed class
- Change in registration status could affect regulatory reporting and investor access
Insights
TL;DR: Form 25 signals the removal of scPharmaceuticals' Nasdaq listing under the exchange's withdrawal/delisting rules.
The filing documents a procedural notification that the issuer's securities will be struck from Nasdaq and references the Exchange Act withdrawal/delisting provisions. It shows Nasdaq and/or the issuer complied with the cited rule sections for removal.
This change alters the trading venue and regulatory status of the listed class of securities; shareholders should note the delisting process timeline and any follow-up notices that explain next steps for trading or registration.
scPharmaceuticals Inc. ha presentato una notifica Form 25 che indica che la classe di titoli della società verrà rimossa dall'elenco e/o dalla registrazione sul Nasdaq Stock Market LLC. Il modulo identifica Nasdaq come mercato di scambio e cita le disposizioni rilevanti delle norme per il ritiro/delisting. La compilazione indica che la Borsa e/o l’emittente ha seguito le regole procedurali che governano un ritiro volontario ai sensi del Securities Exchange Act.
scPharmaceuticals Inc. presentó una Notificación Form 25 indicando que la clase de valores de la empresa será retirada de la cotización y/o del registro en el Nasdaq Stock Market LLC. El formulario identifica a Nasdaq como la bolsa y cita las disposiciones aplicables de retiro/eliminación de listado. El informe indica que la Bolsa y/o el Emisor ha seguido las reglas procesales que rigen una retirada voluntaria conforme a la Exchange Act.
scPharmaceuticals Inc.는 회사의 증권 계열이 나스닥 주식시장 LLC에서 상장 및/또는 등록에서 제거될 것임을 알리는 Form 25 알림을 제출했습니다. 양식은 나스닥을 거래소로 식별하고 해당 인출/상장폐지 규정 조항을 인용합니다. 제출서는 거래소 및/또는 발행인이 Exchange Act에 따라 자발적 인출을 관리하는 절차 규칙을 따랐다고 명시합니다.
scPharmaceuticals Inc. a déposé une notification Form 25 indiquant que la catégorie de valeurs mobilières de la société sera retirée de la cotation et/ou de l'enregistrement sur le Nasdaq Stock Market LLC. Le formulaire identifie Nasdaq comme la bourse et cite les dispositions applicables des règles de retrait/désinscription. Le dépôt indique que la Bourse et/ou l'Émetteur a suivi les règles procédurales régissant un retrait volontaire en vertu de la Exchange Act.
scPharmaceuticals Inc. hat eine Form 25-Mitteilung eingereicht, die darauf hinweist, dass die Wertpapierklasse des Unternehmens aus dem Listing und/oder der Registrierung am Nasdaq Stock Market LLC entfernt wird. Das Formular identifiziert Nasdaq als Börse und verweist auf die einschlägigen Bestimmungen der Abzugs-/Delisting-Regeln. Die Einreichung gibt an, dass die Börse und/oder der Emittent die Verfahrensregeln befolgt hat, die eine freiwillige Entfernung gemäß dem Exchange Act regeln.
FAQ
What does the Form 25 filed for scPharmaceuticals (SCPH) mean?
Which exchange is involved in the SCPH Form 25 filing?
Did the Form 25 state whether the withdrawal was voluntary or involuntary?
Will shareholders still be able to trade SCPH after Form 25?
What rules did the filing reference for the removal?
